Clinuvel Pharmaceuticals
CUV.AX
#6871
Rank
C$0.61 B
Marketcap
$12.28
Share price
-1.17%
Change (1 day)
-11.38%
Change (1 year)

EPS for Clinuvel Pharmaceuticals (CUV.AX)

EPS in 2023: $0.57

According to Clinuvel Pharmaceuticals's latest financial reports the company's current EPS (TTM) is $0.57. In 2023 the company made an earnings per share (EPS) of $0.57 an increase over its 2022 EPS that were of $0.41.

EPS history for Clinuvel Pharmaceuticals from 2000 to 2023

Annual EPS

Year EPS Change
2023$0.5740.79%
2022$0.41-22.53%
2021$0.5361.74%
2020$0.33-12.03%
2019$0.3728.75%
2018$0.2979.08%
2017$0.16-318.99%
2016-$0.07332-71.6%
2015-$0.2636.75%
2014-$0.19-23.66%
2013-$0.25-45.84%
2012-$0.46-18.99%
2011-$0.5625.76%
2010-$0.45-22.24%
2009-$0.58-10.59%
2008-$0.6446.78%
2007-$0.44-34.2%
2006-$0.67-25.89%
2005-$0.9040.91%
2004-$0.6455.12%
2003-$0.4152.02%
2002-$0.2771.69%
2001-$0.16355.46%
2000-$0.03467